Stockreport

BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program

BeOne Medicines Ltd. - American Depositary Shares  (ONC) 
PDF SAN CARLOS, Calif.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medici [Read more]